CN107619421A - The continuous chromatography isolation and purification method of lincomycin - Google Patents
The continuous chromatography isolation and purification method of lincomycin Download PDFInfo
- Publication number
- CN107619421A CN107619421A CN201710852564.1A CN201710852564A CN107619421A CN 107619421 A CN107619421 A CN 107619421A CN 201710852564 A CN201710852564 A CN 201710852564A CN 107619421 A CN107619421 A CN 107619421A
- Authority
- CN
- China
- Prior art keywords
- resin
- product
- lincomycin
- region
- mouths
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- OJMMVQQUTAEWLP-KIDUDLJLSA-N lincomycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 OJMMVQQUTAEWLP-KIDUDLJLSA-N 0.000 title claims abstract description 55
- 229960005287 lincomycin Drugs 0.000 title claims abstract description 51
- OJMMVQQUTAEWLP-UHFFFAOYSA-N Lincomycin Natural products CN1CC(CCC)CC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 OJMMVQQUTAEWLP-UHFFFAOYSA-N 0.000 title claims abstract description 50
- 238000004587 chromatography analysis Methods 0.000 title claims abstract description 50
- 238000000034 method Methods 0.000 title claims abstract description 35
- 238000000746 purification Methods 0.000 title claims abstract description 17
- 238000002955 isolation Methods 0.000 title claims abstract description 6
- 239000000047 product Substances 0.000 claims abstract description 81
- 239000003480 eluent Substances 0.000 claims abstract description 20
- 238000004519 manufacturing process Methods 0.000 claims abstract description 15
- 239000000706 filtrate Substances 0.000 claims abstract description 13
- 229960001595 lincomycin hydrochloride Drugs 0.000 claims abstract description 8
- 238000000926 separation method Methods 0.000 claims abstract description 6
- LFZGYTBWUHCAKF-DCNJEFSFSA-N hydron;(2s,4r)-n-[(1r,2r)-2-hydroxy-1-[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;chloride;hydrate Chemical compound O.Cl.CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 LFZGYTBWUHCAKF-DCNJEFSFSA-N 0.000 claims abstract 4
- 239000011347 resin Substances 0.000 claims description 98
- 229920005989 resin Polymers 0.000 claims description 98
- 239000007788 liquid Substances 0.000 claims description 63
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 63
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 46
- 239000000463 material Substances 0.000 claims description 41
- XUKUURHRXDUEBC-SXOMAYOGSA-N (3s,5r)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-SXOMAYOGSA-N 0.000 claims description 29
- 238000001179 sorption measurement Methods 0.000 claims description 29
- 238000004140 cleaning Methods 0.000 claims description 21
- 238000010521 absorption reaction Methods 0.000 claims description 18
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 14
- 239000012141 concentrate Substances 0.000 claims description 12
- 238000001514 detection method Methods 0.000 claims description 12
- 239000002994 raw material Substances 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 11
- 230000000694 effects Effects 0.000 claims description 10
- 239000002245 particle Substances 0.000 claims description 9
- 238000013461 design Methods 0.000 claims description 7
- 238000011010 flushing procedure Methods 0.000 claims description 7
- 230000004907 flux Effects 0.000 claims description 7
- 238000004088 simulation Methods 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 7
- 230000002745 absorbent Effects 0.000 claims description 6
- 239000002250 absorbent Substances 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- 230000006837 decompression Effects 0.000 claims 1
- 238000005516 engineering process Methods 0.000 abstract description 6
- 238000002360 preparation method Methods 0.000 abstract description 3
- 238000010828 elution Methods 0.000 abstract description 2
- 230000007613 environmental effect Effects 0.000 abstract 1
- 230000008929 regeneration Effects 0.000 abstract 1
- 238000011069 regeneration method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000005406 washing Methods 0.000 abstract 1
- 238000002425 crystallisation Methods 0.000 description 12
- 230000008025 crystallization Effects 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000012535 impurity Substances 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- POUMFISTNHIPTI-BOMBIWCESA-N hydron;(2s,4r)-n-[(1r,2r)-2-hydroxy-1-[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;chloride Chemical compound Cl.CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 POUMFISTNHIPTI-BOMBIWCESA-N 0.000 description 4
- 239000011344 liquid material Substances 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- DZSDDKNXMARQMJ-AVXYAQEDSA-N (2S,4R)-4-ethyl-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methylpyrrolidine-2-carboxamide Chemical compound CN1C[C@H](CC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 DZSDDKNXMARQMJ-AVXYAQEDSA-N 0.000 description 2
- 241001662103 Cryptocarya corrugata Species 0.000 description 2
- CWPMAVJRTHPUNS-UHFFFAOYSA-N Lincomycin B Natural products CCC1CC(NC(=O)C(C(C)O)C2OC(SC)C(O)C(O)C2O)N(C)C1 CWPMAVJRTHPUNS-UHFFFAOYSA-N 0.000 description 2
- DZSDDKNXMARQMJ-UHFFFAOYSA-N N-Desmethyllincomycin Natural products CN1CC(CC)CC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 DZSDDKNXMARQMJ-UHFFFAOYSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 239000003610 charcoal Substances 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241001655322 Streptomycetales Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Abstract
Description
Date | Feed liquid purity (%) | Primary crystallization (%) | Secondary crystallization (%) |
No. 9 | 99.12 | 99.52 | 99.54 |
No. 10-11 | 99.26 | 99.57 | 99.63 |
Date | Feed liquid purity (%) | Primary crystallization (%) | Secondary crystallization (%) |
No. 27 | 99.53 | 99.68 | 99.74 |
No. 28 first | 99.58 | 99.74 | 99.79 |
No. 28 second batchs | 99.6 | 99.71 | 99.77 |
Resin model | Particle diameter | The uniformity (%) | Feed liquid purity (%) | Primary crystallization (%) | Secondary crystallization (%) |
HZ-802 | 50~100 | ≥95 | 99.53 | 99.68 | 99.74 |
HZ-802 | > 100 | ≥95 | 99.53 | 85.94 | 98.12 |
HZ-802 | > 100 | < 95 | 99.53 | 84.72 | 96.65 |
AB-8 | 50~100 | ≥95 | 99.53 | 99.52 | 99.69 |
AB-8 | > 100 | ≥95 | 99.53 | 86.15 | 97.95 |
AB-8 | > 100 | < 95 | 99.53 | 83.18 | 96.35 |
Lan Xin -30 | 50~100 | ≥95 | 99.53 | 99.45 | 99.66 |
Lan Xin -30 | 50~100 | < 95 | 99.53 | 86.35 | 98.37 |
Lan Xin -30 | > 100 | < 95 | 99.53 | 84.17 | 96.28 |
D-101 | 50~100 | ≥95 | 99.53 | 61.84 | 65.58 |
D-101 | 50~100 | < 95 | 99.53 | 59.75 | 62.38 |
D-101 | > 100 | < 95 | 99.53 | 55.13 | 58.95 |
BS-75 | 50~100 | ≥95 | 99.53 | 46.38 | 66.29 |
BS-75 | 50~100 | < 95 | 99.53 | 44.68 | 60.37 |
BS-75 | > 100 | < 95 | 99.53 | 34.98 | 54.76 |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710852564.1A CN107619421B (en) | 2017-09-19 | 2017-09-19 | The continuous chromatography isolation and purification method of lincomycin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710852564.1A CN107619421B (en) | 2017-09-19 | 2017-09-19 | The continuous chromatography isolation and purification method of lincomycin |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107619421A true CN107619421A (en) | 2018-01-23 |
CN107619421B CN107619421B (en) | 2018-10-12 |
Family
ID=61090612
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710852564.1A Active CN107619421B (en) | 2017-09-19 | 2017-09-19 | The continuous chromatography isolation and purification method of lincomycin |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107619421B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108872458A (en) * | 2018-06-26 | 2018-11-23 | 江西国药有限责任公司 | A kind of detection method of lincomycin fermentation liquid |
CN110152353A (en) * | 2019-06-18 | 2019-08-23 | 大连博迈科技发展有限公司 | A kind of continuous chromatography device and arasaponin production method |
CN112645993A (en) * | 2020-12-24 | 2021-04-13 | 西安蓝晓科技新材料股份有限公司 | Purification method of high-purity lincomycin hydrochloride |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1301703A (en) * | 1999-12-30 | 2001-07-04 | 董斌 | Extracting technology for lincomycin |
CN1709902A (en) * | 2005-07-18 | 2005-12-21 | 亓平言 | Process for extracting lincomycin |
CN102746348A (en) * | 2011-04-19 | 2012-10-24 | 上海医药工业研究院 | Method for separation of lincomycin |
CN102796149A (en) * | 2012-07-25 | 2012-11-28 | 无锡济民可信山禾药业股份有限公司 | Continuous separation and purification technology for etimicin |
CN104447909A (en) * | 2014-10-28 | 2015-03-25 | 无锡济民可信山禾药业股份有限公司 | Continuous-chromatography separating and purifying method of etimicin sulfate |
CN104861007A (en) * | 2015-06-02 | 2015-08-26 | 江苏海阔生物医药有限公司 | Method for extracting lincomycin by using resin to adsorb fermentation stock solution |
CN105524128A (en) * | 2015-12-25 | 2016-04-27 | 无锡济民可信山禾药业股份有限公司 | Continuous chromatographic separation technology of gentamycin C1a |
-
2017
- 2017-09-19 CN CN201710852564.1A patent/CN107619421B/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1301703A (en) * | 1999-12-30 | 2001-07-04 | 董斌 | Extracting technology for lincomycin |
CN1709902A (en) * | 2005-07-18 | 2005-12-21 | 亓平言 | Process for extracting lincomycin |
CN102746348A (en) * | 2011-04-19 | 2012-10-24 | 上海医药工业研究院 | Method for separation of lincomycin |
CN102796149A (en) * | 2012-07-25 | 2012-11-28 | 无锡济民可信山禾药业股份有限公司 | Continuous separation and purification technology for etimicin |
CN104447909A (en) * | 2014-10-28 | 2015-03-25 | 无锡济民可信山禾药业股份有限公司 | Continuous-chromatography separating and purifying method of etimicin sulfate |
CN104861007A (en) * | 2015-06-02 | 2015-08-26 | 江苏海阔生物医药有限公司 | Method for extracting lincomycin by using resin to adsorb fermentation stock solution |
CN105524128A (en) * | 2015-12-25 | 2016-04-27 | 无锡济民可信山禾药业股份有限公司 | Continuous chromatographic separation technology of gentamycin C1a |
Non-Patent Citations (1)
Title |
---|
宋航 编: "《制药分离工程》", 31 August 2011, 华东理工化学出版社有限公司 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108872458A (en) * | 2018-06-26 | 2018-11-23 | 江西国药有限责任公司 | A kind of detection method of lincomycin fermentation liquid |
CN108872458B (en) * | 2018-06-26 | 2020-06-16 | 江西国药有限责任公司 | Detection method of lincomycin fermentation liquor |
CN110152353A (en) * | 2019-06-18 | 2019-08-23 | 大连博迈科技发展有限公司 | A kind of continuous chromatography device and arasaponin production method |
CN112645993A (en) * | 2020-12-24 | 2021-04-13 | 西安蓝晓科技新材料股份有限公司 | Purification method of high-purity lincomycin hydrochloride |
Also Published As
Publication number | Publication date |
---|---|
CN107619421B (en) | 2018-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105524128B (en) | A kind of continuous chromatography separating technology of Gentamicin C1a | |
CN106928323B (en) | Preparation method of high-purity oritavancin key intermediate A82846B | |
CN107619421B (en) | The continuous chromatography isolation and purification method of lincomycin | |
CN109721487B (en) | Process for efficiently purifying shikimic acid by using continuous ion exchange technology | |
CN105001309B (en) | A kind of isolation and purification method of Dalbavancin | |
CN102796149B (en) | Continuous separation and purification technology for etimicin | |
CN107434823A (en) | A kind of oritavancin intermediate A 82846B purification process | |
CN1266159C (en) | Process for preparing gentamicin Cla | |
CN111018933A (en) | Fructus momordicae extract product and preparation method and application thereof | |
CN107602404B (en) | Method for extracting high-purity betaine from molasses alcohol waste liquid | |
CN115260255A (en) | Method for separating and purifying 2' -fucosyllactose by using simulated moving bed | |
CN102311486B (en) | Method for separating and extracting enramycin by using macroporous weakly-acidic cationic resin | |
EP2987800B1 (en) | Method for separating and purifying recombined human lactoferrin from rice seeds | |
CN112409426B (en) | Preparation method of sisomicin sulfate | |
CN1107065C (en) | Methof of extracting isoflavone, saponin, oligosaccharide and protein simultaneously from defatted soybean dregs | |
CN106565827B (en) | Method for highly purifying glycopeptide compound | |
CN106589075B (en) | Purification method of teicoplanin | |
CN110117310B (en) | Purification method of daptomycin | |
CN112300229A (en) | Method for purifying acarbose from acarbose fermentation liquor | |
CN111333687A (en) | Method for extracting franocidine sulfate from neomycin sulfate | |
CN113845422B (en) | Process for preparing L-chicoric acid from Echinacea purpurea in batches and application thereof | |
CN111499669A (en) | Method for refining spiramycin by adopting two DAC columns | |
CN102190691A (en) | Method for preparing high-purity 4'-epi-daunorubicin | |
CN101279980B (en) | Separation and purification method of cefminox sodium and preparation of cefminox sodium freeze-dried powder injection | |
CN116284254B (en) | Method for extracting high-purity high-content polymyxin B sulfate single component from fermentation liquor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Continuous chromatographic separation and purification of lincomycin Effective date of registration: 20211223 Granted publication date: 20181012 Pledgee: Bank of China Limited Nanchang Qingyunpu sub branch Pledgor: JIANGXI JEMINCARE GROUP Co.,Ltd. Registration number: Y2021980016166 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20220902 Granted publication date: 20181012 Pledgee: Bank of China Limited Nanchang Qingyunpu sub branch Pledgor: JIANGXI JEMINCARE GROUP Co.,Ltd. Registration number: Y2021980016166 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Continuous chromatographic separation and purification of lincomycin Effective date of registration: 20220905 Granted publication date: 20181012 Pledgee: Bank of China Limited Nanchang Qingyunpu sub branch Pledgor: JIANGXI JEMINCARE GROUP Co.,Ltd. Registration number: Y2022980014583 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230830 Granted publication date: 20181012 Pledgee: Bank of China Limited Nanchang Qingyunpu sub branch Pledgor: JIANGXI JEMINCARE GROUP Co.,Ltd. Registration number: Y2022980014583 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Continuous chromatographic separation and purification method for lincomycin Effective date of registration: 20230831 Granted publication date: 20181012 Pledgee: Bank of China Limited Nanchang Qingyunpu sub branch Pledgor: JIANGXI JEMINCARE GROUP Co.,Ltd. Registration number: Y2023980054957 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |